Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Sinus stent registry shows symptom relief in chronic sinusitis patients

NCT ID NCT05925985

Knowledge-focused Sponsor: Medtronic Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study followed 215 people with chronic sinusitis who received a corticosteroid-releasing sinus stent during sinus surgery. Researchers tracked safety and symptom changes over 6 to 12 months using a standard symptom questionnaire. The goal was to confirm the stent's long-term safety and real-world performance.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
corticosteroid-eluting sinus stent
What this could lead to
If results confirm safety and symptom improvement, it supports continued use of these stents to manage chronic sinusitis after surgery.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove the stent caused the improvements. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

215 people

The number who actually took part.

Started

Jun 2023

Finished

Sep 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

European CRS population implanted with Propel implants

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements. * Patient has or is intended to receive or be treated with an eligible Medtronic product * Patient is consented within the enrollment window of the therapy received, as applicable Exclusion Criteria: * Patient who is, or is expected to be, inaccessible for follow-up * Participation is excluded by local law * Patient is currently enrolled or plans to enroll in concurrent drug/device study that may confound the PSR results

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic rhinosinusitis (diagnosis) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic rhinosinusitis disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic rhinosinusitis (diagnosis)

Contacts and locations

Locations

  • HNO Praxis & Rhinologie Zentrum München

    München, Germany

  • Helios Dr Horst Schmidt Kliniken

    Wiesbaden, Germany

  • Imperial College Healthcare NHS Trust - Charing Cross Hospital

    London, United Kingdom

  • Katholisches Krankenhaus Hagen

    Hagen, Germany

  • Saint Elisabeth Krankenhaus Köln-Hohenlind

    Cologne, Germany

  • Städtisches Klinikum Karlsruhe GmbH

    Karlsruhe, Germany

  • Universitätsklinikum Freiburg Klinik für Hals, Nasen und Ohrenheilkunde

    Freiburg im Breisgau, Germany

  • Universitätsklinikum Münster Klinik für Hals, Nasen und Ohrenheilkunde

    Münster, Germany

  • Universitätsklinikum Schleswig-Holstein Campus Lübeck

    Lübeck, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.